Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd (“Avistone”), an innovative biotechnology company focused…
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term…
PM Narendra Modi inaugurates Kanpur Metro, built by Afcons
MUMBAI, India, May 30, 2025 /PRNewswire/ -- Honourable Prime Minister Shri Narendra Modi on…
Suraj Estate Developers Reports Robust FY25 Performance with 33% Growth in Revenue and 48% Jump in PAT
MUMBAI, India, May 29, 2025 /PRNewswire/ -- Suraj Estate Developers Ltd. today…